Global Blood Therapeutics Inc.
US ˙ NASDAQ ˙ US37890U1088
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityGBT / Global Blood Therapeutics Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership46,344 shares
Latest Disclosed Value $ 3,156,026
Jefferies Group LLC ownership in GBT / Global Blood Therapeutics Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 46,344 shares of Global Blood Therapeutics Inc. (US:GBT) valued at $3,156,026 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 15, 2022 disclosing 15,364 shares of Global Blood Therapeutics Inc.. This represents a change in shares of 201.64% during the quarter. The current value of the position is $3,174,101 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (GBT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GBT / Global Blood Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 46,344 30,980 201.64 3,156 542.77 0.0264
2022-11-14 2022-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 144,610 129,246 9,470 0.0754
2022-08-15 2022-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 15,364 1,466 10.55 491 2.08 0.0038
2023-09-21 2022-03-31 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 13,898 -5,994 -30.13 481 -17.35 0.0030
2022-05-16 2022-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 13,898 -5,994 481 0.0028
2022-02-14 2021-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 19,892 -5,108 -20.43 582 -8.63 0.0031
2023-09-21 2021-09-30 13F/A-2 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 25,000 19,506 355.04 637 231.77 0.0046
2021-12-17 2021-09-30 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 25,000 19,506 637 0.0044
2021-11-15 2021-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 25,000 19,506 637 0.0041
2023-09-21 2021-06-30 13F/A-2 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 5,494 5,494 192 0.0012
2021-08-20 2021-06-30 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 5,494 5,494 192 0.0011
2021-08-16 2021-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 5,494 5,494 192 0.0011
2023-09-21 2020-12-31 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 0 -22,351 -100.00 0 -100.00
2021-02-16 2020-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 0 -22,351 0
2020-11-13 2020-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 22,351 -70,736 -75.99 1,232 -79.04 0.0136
2020-11-02 2020-06-30 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 93,087 25,049 36.82 5,877 69.07 0.0692
2020-08-14 2020-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 93,087 25,049 5,877 78,974.2724
2020-05-15 2020-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 68,038 67,971 101,449.25 3,476 69,420.00 0.0432
2020-02-13 2019-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 67 -21,933 -99.70 5 -99.53 0.0000
2019-11-13 2019-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 22,000 11,840 116.54 1,067 99.81 0.0083
2019-08-14 2019-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 10,160 10,160 -53.82 534 -49.95 0.0039
2019-05-15 2019-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 0 -17,357 -100.00 0 -100.00
2019-02-14 2018-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 17,357 -3,950 -18.54 713 -11.98 0.0058
2018-11-14 2018-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 21,307 21,307 22.76 810 13.60 0.0053
2017-02-14 2016-12-31 13F/A-1 GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 0 -25,000 -100.00 0 -100.00
2016-11-14 2016-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 25,000 25,000 576 0.0030
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-06-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 0 0 n/a n/a n/a
2023-09-21 2022-03-31 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 300 50.00 10 66.67 n/a n/a n/a
2022-05-16 2022-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 300 10 n/a n/a n/a
2022-02-14 2021-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 200 -99.60 6 -99.53 n/a n/a n/a
2021-12-17 2021-09-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 50,000 1,274 n/a n/a n/a
2023-09-21 2021-09-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 50,000 0.00 1,274 -27.24 n/a n/a n/a
2021-11-15 2021-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 50,000 1,274 n/a n/a n/a
2021-08-20 2021-06-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 50,000 1,751 n/a n/a n/a
2023-09-21 2021-06-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 50,000 1,751 n/a n/a n/a
2021-08-16 2021-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 5,000,000 1,751 n/a n/a n/a
2020-11-13 2020-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-02 2020-06-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Call 67,000 4,230 n/a n/a n/a
2020-08-14 2020-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 67,000 4,230 n/a n/a n/a
2020-02-13 2019-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-13 2019-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 95,000 -24.84 4,609 -30.68 n/a n/a n/a
2019-08-14 2019-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 126,400 145.91 6,649 144.36 n/a n/a n/a
2019-05-15 2019-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 51,400 -26.78 2,721 -5.59 n/a n/a n/a
2019-02-14 2018-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 70,200 -67.92 2,882 -65.34 n/a n/a n/a
2018-11-14 2018-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 218,800 -18.45 8,314 -31.44 n/a n/a n/a
2018-08-14 2018-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 268,300 22.62 12,127 45.86 n/a n/a n/a
2016-08-12 2016-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-11 2016-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Call 30,000 476 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2020-12-31 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 0 0 n/a n/a n/a
2020-11-13 2020-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 70,000 -53.80 3,860 -59.64 n/a n/a n/a
2020-11-02 2020-06-30 13F/A GLOBAL BLOOD THERAPEUTICS IN COM Put 151,500 10.83 9,564 36.94 n/a n/a n/a
2020-08-14 2020-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 151,500 9,564 n/a n/a n/a
2020-05-15 2020-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 136,700 738.65 6,984 438.89 n/a n/a n/a
2020-02-13 2019-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 16,300 -57.77 1,296 -36.16 n/a n/a n/a
2019-08-14 2019-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 38,600 739.13 2,030 735.39 n/a n/a n/a
2019-05-15 2019-03-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 4,600 -83.27 243 -78.48 n/a n/a n/a
2019-02-14 2018-12-31 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 27,500 -18.88 1,129 -12.34 n/a n/a n/a
2018-11-14 2018-09-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 33,900 245.92 1,288 190.74 n/a n/a n/a
2018-08-14 2018-06-30 13F GLOBAL BLOOD THERAPEUTICS IN COM Put 9,800 443 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.